BR9907882A - Uso de compostos de 1,5-didesóxi-1,5-imino-d-glucitol n-substituìdos para o tratamento de infecções de vìrus de hepatite - Google Patents

Uso de compostos de 1,5-didesóxi-1,5-imino-d-glucitol n-substituìdos para o tratamento de infecções de vìrus de hepatite

Info

Publication number
BR9907882A
BR9907882A BR9907882-1A BR9907882A BR9907882A BR 9907882 A BR9907882 A BR 9907882A BR 9907882 A BR9907882 A BR 9907882A BR 9907882 A BR9907882 A BR 9907882A
Authority
BR
Brazil
Prior art keywords
dideoxy
imino
hepatitis virus
virus infections
unsubstituted
Prior art date
Application number
BR9907882-1A
Other languages
English (en)
Inventor
Richard A Mueller
Martin L Bryant
Richard A Partis
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/023,401 external-priority patent/US20030100532A1/en
Application filed by Searle & Co filed Critical Searle & Co
Publication of BR9907882A publication Critical patent/BR9907882A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Abstract

Patente de Invenção: <B>"USO DE COMPOSTOS DE 1,5-DIDESóXI-1,5-IMINO-D-GLUCITOL N-SUBSTITUìDOS PARA O TRATAMENTO DE INFECçõES DE VìRUS DE HEPATITE"<D>. Providos são métodos e composições para o tratamento de infecções de vírus de hepatite em mamíferos, especialmente seres humanos. Os métodos compreende (1) administração de compostos 1,5-didesóxi-,1,5-imino-D-glucitol N-substituídos sozinhos ou em combinação com agentes antivirais de nucleosídeo, agentes antivirais de nucleotídeo, suas misturas, ou agentes de imunomodulação/imunoestimulação, ou (2) administracão de compostos 1,5-didesóxi-,1,5-imino-D-glucitol N-substituídos sozinhos ou em combinação com agentes antivirais de nucleosídeo, agentes antivirais de nucleotídeo ou suas misturas e agentes de imunomodulação/imunoestimulante.
BR9907882-1A 1998-02-12 1999-02-12 Uso de compostos de 1,5-didesóxi-1,5-imino-d-glucitol n-substituìdos para o tratamento de infecções de vìrus de hepatite BR9907882A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7450898P 1998-02-12 1998-02-12
US09/023,401 US20030100532A1 (en) 1997-02-14 1998-02-12 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
PCT/US1999/001874 WO1999040916A1 (en) 1998-02-12 1999-02-12 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections

Publications (1)

Publication Number Publication Date
BR9907882A true BR9907882A (pt) 2000-10-17

Family

ID=26697090

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9907882-1A BR9907882A (pt) 1998-02-12 1999-02-12 Uso de compostos de 1,5-didesóxi-1,5-imino-d-glucitol n-substituìdos para o tratamento de infecções de vìrus de hepatite

Country Status (16)

Country Link
US (2) US6809083B1 (pt)
EP (1) EP1061922B9 (pt)
JP (1) JP2002502875A (pt)
KR (1) KR20010040937A (pt)
AT (1) ATE331515T1 (pt)
AU (2) AU762125B2 (pt)
BR (1) BR9907882A (pt)
CA (1) CA2319713C (pt)
DE (1) DE69932154T2 (pt)
EA (1) EA004705B1 (pt)
ES (1) ES2272054T3 (pt)
ID (1) ID27290A (pt)
MY (1) MY122185A (pt)
TR (1) TR200002323T2 (pt)
TW (1) TWI222867B (pt)
WO (1) WO1999040916A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100532A1 (en) 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
JP2002502875A (ja) 1998-02-12 2002-01-29 ジー・ディー・サール・アンド・カンパニー 肝炎ウイルス感染症を処置するためのｎ−置換−１，５−ジデオキシ−１，５−イミノ−ｄ−グルシトール化合物の使用
CA2362914C (en) 1999-02-12 2009-04-14 G.D. Searle & Co. Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
AU3858600A (en) * 1999-02-12 2001-02-19 G.D. Searle & Co. Glucamine compounds for treating hepatitis virus infections
ES2302697T3 (es) 1999-08-10 2008-08-01 The Chancellor, Masters And Scholars Of The University Of Oxford Compuestos n-alquilicos de cadena larga y derivados oxa de los mismos y uso como composiciones antivirales.
AU2001236938A1 (en) * 2000-02-14 2001-08-27 Pharmacia Corporation Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
AU2013203974B2 (en) * 2000-05-23 2016-06-02 Idenix Pharmaceuticals, Inc. Methods and compositions for treating hepatitis C virus
OA12382A (en) 2000-05-26 2006-04-17 Novirio Pharmaceuticals Ltd Methods and compositions for treating flavivirusesand pestiviruses.
WO2003037265A2 (en) * 2001-10-30 2003-05-08 Thomas Jefferson University Method of treating viral infections
KR20070053229A (ko) * 2004-08-13 2007-05-23 미게닉스 인코포레이티드 헤파드나비리대 감염을 치료 또는 예방하기 위한 조성물 및방법
SI2027137T1 (sl) * 2005-06-08 2015-06-30 Amicus Therapeutics, Inc. Čiščenje imino in amino sladkorja
BRPI0613221A2 (pt) * 2005-06-08 2010-12-28 Amicus Therapeutics Inc furanose cristalina e método para produzir uma furanose cristalina
JP2008545800A (ja) * 2005-06-08 2008-12-18 アミカス セラピューティックス インコーポレイテッド トリフラート化化合物の安定化
US7473683B2 (en) 2005-09-14 2009-01-06 The Board Of Trustees Of The Leland Stanford Junior University Nonpolar thymidine analogs
WO2007140184A2 (en) * 2006-05-24 2007-12-06 United Therapeutics Corporation Deoxynojirimycin and d-arabinitol analogs and methods of using
WO2008088581A2 (en) * 2006-08-02 2008-07-24 United Therapeutics Corporation Liposome treatment of viral infections
US8097728B2 (en) * 2007-04-30 2012-01-17 Philadelphia Health & Education Corporation Iminosugar compounds with antiflavirus activity
WO2009118658A2 (en) * 2008-03-26 2009-10-01 University Of Oxford Endoplasmic reticulum targeting liposomes
KR20120042716A (ko) 2009-02-23 2012-05-03 유나이티드 세러퓨틱스 코오포레이션 이미노슈가 및 바이러스성 질환을 치료하는 방법
CA2757026A1 (en) * 2009-03-27 2010-09-30 The Chancellor, Masters And Scholars Of The University Of Oxford Cholesterol level lowering liposomes
US8426445B2 (en) 2009-06-12 2013-04-23 United Therapeutics Corporation Iminosugars and methods of treating bunyaviral and togaviral diseases
CN102625801B (zh) * 2009-09-04 2015-09-09 联合治疗公司 治疗痘病毒感染的方法
IN2014MN02539A (pt) 2012-06-06 2015-07-24 Unither Virology Llc
US10428022B2 (en) 2014-11-05 2019-10-01 Emergent Virology Llc Iminosugars useful for the treatment of viral diseases
IL295692A (en) * 2016-01-08 2022-10-01 Arbutus Biopharma Corp Medical preparations and methods for treating jaundice b

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU33730B (en) 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
GB1555654A (en) 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
US4065562A (en) 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
US4012448A (en) 1976-01-15 1977-03-15 Stanford Research Institute Synthesis of adriamycin and 7,9-epiadriamycin
NO154918C (no) 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
GB2020278B (en) 1978-05-03 1983-02-23 Nippon Shinyaku Co Ltd Moranoline dervitives
JPS5562004A (en) 1978-11-02 1980-05-10 Kureha Chem Ind Co Ltd Control agent against plant viral disease
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
DE3049446A1 (de) 1980-12-30 1982-07-29 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 1,5-didesoxy-1,5-imino-d-glucitol und dessen n-derivaten
ZA822995B (en) 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
DE3650377T2 (de) 1985-12-23 1996-02-22 Hutchinson Fred Cancer Res Regulierung der retroviralen replikation, infektion und pathogenese.
GB2186485B (en) 1986-02-13 1988-09-07 Ethical Pharma Ltd Slow release formulation
DE3611841A1 (de) 1986-04-09 1987-10-15 Bayer Ag Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten
PT89266B (pt) 1987-12-21 1993-11-30 Monsanto Co Metodo para a inibicao de virus da imunodeficiencia humana utilizando um derivado n-n-butilo de desoxinojirimicina
US4849430A (en) * 1988-03-09 1989-07-18 Monsanto Company Method of inhibiting virus
FI101344B (fi) 1988-03-31 1998-06-15 Tanabe Seiyaku Co Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseut tisesti aktiivista ainetta
US5041441A (en) 1988-04-04 1991-08-20 The Regents Of The University Of Michigan Method of chemotherapy using 1-phenyl-2-decanoylamino-3-morpholino-1-propanol
EP0350012A3 (en) 1988-07-08 1990-09-05 Meiji Seika Kaisha Ltd. Antiviral composition
US5003072A (en) * 1988-11-03 1991-03-26 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-D-glucitol derivatives
US5310745A (en) 1988-11-03 1994-05-10 G. D. Searle & Co. Antiviral compounds
US5221746A (en) * 1988-11-03 1993-06-22 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-D-glucitol derivatives
US5144037A (en) 1988-11-03 1992-09-01 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-d-glucitol derivatives
US4957926A (en) 1988-12-22 1990-09-18 Monsanto Company Method of treating herpesviruses
US5011829A (en) 1989-06-02 1991-04-30 G. D. Searle & Co. Pharmaceutical composition and method of inhibiting virus
US5030638A (en) * 1990-02-26 1991-07-09 G. D. Searle & Co. Method of antiviral enhancement
DE4009561A1 (de) * 1990-03-24 1991-09-26 Bayer Ag Neue desoxynojirimycinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5536732A (en) 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
US5151519A (en) 1990-05-07 1992-09-29 G. D. Searle & Co. Process for the preparation of 1,5-(alkylimino)-1,5-dideoxy-d-glucitol and derivatives thereof
ES2087277T3 (es) 1990-09-20 1996-07-16 Monsanto Co Procedimiento para producir 1-desoxinojirimicina n-sustituida.
US5444063A (en) * 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US5190765A (en) 1991-06-27 1993-03-02 Alza Corporation Therapy delayed
ZA931934B (en) 1992-03-18 1993-03-18 Us Bioscience Compostitions of N-(phosphonoacetyl)-L-aspartic acid and methods of their use as broad spectrum antivirals
IL105090A (en) 1992-03-18 1998-08-16 Us Bioscience Acid N) phosphonoacetyl (Aspartic L in a broad spectrum antiviral agent
US5258518A (en) 1992-04-01 1993-11-02 G. D. Searle & Co. 2-substituted tertiary carbinol derivatives of deoxynojirimycin
US5331096A (en) 1992-04-01 1994-07-19 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
WO1994004546A1 (en) 1992-08-14 1994-03-03 Nippon Shinyaku Co., Ltd. Moranoline derivative
FR2700267B1 (fr) 1993-01-13 1995-03-17 Oreal N-acyl amino déoxy alditols, et leur utilisation dans des compositions cosmétiques ou dermopharmaceutiques.
DE69419601T2 (de) 1993-03-17 1999-12-02 Kao Corp Aminderivate und sie enthaltende dermatologische zubereitungen
US5399567A (en) 1993-05-13 1995-03-21 Monsanto Company Method of treating cholera
AU7518694A (en) 1993-08-20 1995-03-21 G.D. Searle & Co. Retroviral protease inhibitors and combinations thereof
US6093702A (en) * 1993-12-20 2000-07-25 The United States Of America As Represented By The Department Of Health And Human Services Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
PT739205E (pt) * 1994-01-13 2000-04-28 Monsanto Co Utilizacao de derivados de 1,5-didesoxi-1,5-imino-d-glucitol para o tratamento de infeccoes com o virus da hepatite b
AU1876095A (en) * 1994-02-25 1995-09-11 G.D. Searle & Co. Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
US5451679A (en) 1994-03-08 1995-09-19 G. D. Searle & Co. 2-chloro and 2-bromo derivatives of 1,5-iminosugars
US5703058A (en) * 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
FR2731150B1 (fr) 1995-03-03 1997-04-18 Oreal Utilisation de composes amphiphiles en tant qu'agent epaississant de milieux non aqueux
US5763470A (en) 1995-06-07 1998-06-09 Sugen Inc. Benzopyran compounds and methods for their use
WO1997000881A1 (en) 1995-06-22 1997-01-09 Nippon Shinyaku Co., Ltd. Moranoline derivatives
CN100382804C (zh) * 1997-02-14 2008-04-23 G·D·瑟尔公司 N-取代的-1,5-二脱氧-1,5-亚氨基-d-山梨醇化合物在制备治疗肝炎病毒感染的药物中的用途
EP1037636A4 (en) 1997-12-11 2004-08-18 Univ Oxford INHIBITATION OF MEMBRANE-TIED VIRAL REPLICATION
JP2002502875A (ja) 1998-02-12 2002-01-29 ジー・ディー・サール・アンド・カンパニー 肝炎ウイルス感染症を処置するためのｎ−置換−１，５−ジデオキシ−１，５−イミノ−ｄ−グルシトール化合物の使用

Also Published As

Publication number Publication date
ES2272054T3 (es) 2007-04-16
US20050267153A1 (en) 2005-12-01
CA2319713C (en) 2012-06-26
ID27290A (id) 2001-03-22
EA004705B1 (ru) 2004-06-24
AU762125B2 (en) 2003-06-19
US6809083B1 (en) 2004-10-26
WO1999040916A1 (en) 1999-08-19
EP1061922B1 (en) 2006-06-28
EP1061922B9 (en) 2007-03-07
JP2002502875A (ja) 2002-01-29
EP1061922A1 (en) 2000-12-27
ATE331515T1 (de) 2006-07-15
TWI222867B (en) 2004-11-01
KR20010040937A (ko) 2001-05-15
TR200002323T2 (tr) 2000-12-21
AU2003248024A1 (en) 2003-10-30
CA2319713A1 (en) 1999-08-19
AU2759599A (en) 1999-08-30
DE69932154T2 (de) 2007-05-31
DE69932154D1 (de) 2006-08-10
EA200000836A1 (ru) 2001-04-23
MY122185A (en) 2006-03-31

Similar Documents

Publication Publication Date Title
BR9907882A (pt) Uso de compostos de 1,5-didesóxi-1,5-imino-d-glucitol n-substituìdos para o tratamento de infecções de vìrus de hepatite
CA2362914A1 (en) Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
AU6169298A (en) Use of (n)-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combinationtherapy for treating hepatitis virus infections
NO982556L (no) Behandling av CNS-virkningene av HIV med VX-478, alene eller i kombinasjon med AZT eller 3TC
EP1435974A4 (en) METHOD AND COMPOSITIONS FOR TREATING HEPATITIS C VIRUS WITH 4&#39;-MODIFIED NUCLEOSIDES
PT100199A (pt) Combinacao antiviral de nucleosidos e processo para a sua preparacao
MY141594A (en) 3&#39;-PRODRUGS OF 2&#39;-DEOXY-ß-L-NUCLEOSIDES
AP2005003213A0 (en) 2&#39;-C-methyl-3&#39;-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections.
DE69426904D1 (de) Phosphonat-Nukleotid Ester-Derivate
EP1128832A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND RELATED DISEASES
BR0309581A (pt) Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
ID27457A (id) Komposisi untuk pengobatan hiv dan infeksi virus lainnya
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
ATE231839T1 (de) Polyaromatische antivirale zusammensetzungen
ITBO930422A0 (it) Unita&#39; per la lavorazione di pezzi in legno.
HUP0100087A3 (en) Nucleosides analogues, the use thereof for producing medicaments useful against retroviral infections and hepatitis b virus and the same medicaments
ES2102772T3 (es) Compuesto citotoxico y antiviral.
ITBZ930004V0 (it) Disposizione di tassello,in particolare per il fissaggio di guarnitu- re per mobili.
EP0453247A3 (en) Anti-viral compounds
AR019532A1 (es) COMPOSICIoN FARMACÉUTICA DEL COMPUESTO 1,5-DIDEOXI-1,5-IMIN-D-GLUCITOL N-SUSTITUIDO
BR0002640A (pt) Uso de simeticona para tratar colite ulcerativa
BR9106596A (pt) Processo para o tratamento ou profilaxia de uma infeccao associada com retrovirus,uso,composicao farmaceutica para o tratamento ou profilaxia de uma infeccao associada com retrovirus,e,composto
DK0459176T3 (da) Oligophosphater med antiviral virkning
FI901607A0 (fi) Laekemedel och dess anvaendning foer behandling av parasitos.
BR7903130U (pt) Disposição construtiva introduzida em rosetas/entradas

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.